Involvement of β-arrestin-2 and Clathrin in Agonist-Mediated Internalization of the Human Cannabinoid CB2 Receptor

ISSN: 1874-4702 (Online)
ISSN: 1874-4672 (Print)

Volume 10, 4 Issues, 2017

Download PDF Flyer

Current Molecular Pharmacology

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Michael Kahn
University of Southern California
1450 Biggy Street
Los Angeles, NRT 4501, CA 90033

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Involvement of β-arrestin-2 and Clathrin in Agonist-Mediated Internalization of the Human Cannabinoid CB2 Receptor

Current Molecular Pharmacology, 7(1): 67-80.

Author(s): Xiaopan Chen, Congxia Zheng, Jing Qian, Steven W. Sutton, Zhen Wang, Jianxin Lv, Changlu Liu and Naiming Zhou.

Affiliation: College of Life Sciences, Zhejiang University, Zijingang Campus, 388 Yuhang Tang Rd., Hangzhou, 310058, China.


The CB2 cannabinoid receptor is a promising therapeutic target for the treatment of inflammatory diseases, neuropathic pain, liver diseases, cancer and cardiovascular diseases. Obtaining detailed information on the internalization and trafficking of the human CB2 receptor in response to agonist will have a significant impact on drug discovery. Visualization and quantitative detection of EGFP-tagged CB2 receptor showed that, upon WIN55,212-2 stimulation, the CB2 receptor was rapidly internalized in a dose- and time-dependent manner from the cell membrane into the cytoplasm. Pretreatment with hypertonic sucrose, MDC clathrin inhibitor, or siRNA-mediated knock-down of clathrin heavy chain led to significant inhibition of agonist-induced CB2 internalization. Using the RNA interference method, we showed that knockdown of β-arrestin2 expression significantly impaired receptor internalisation. Further investigation demonstrated that the internalized CB2 receptors were co-localized with the early endosome probe and were recycled to the cell surface after the removal of agonist, but treatment with specific cell-permeable proteasome inhibitor MG132 a inhibited the recycling of internalized CB2 receptor, suggesting that the proteasome-mediated degradation pathway may be involved in CB2 internalization. Moreover, the single residue Ser352 and residue cluster S335S336T338T340 at the C-terminal tail are shown to be essential for receptor phosphorylation and β-arrestin2 association. These data provide new insights into the mechanisms regulating agonist-mediated internalization and trafficking of the human CB2 receptor.


β-arrestin, cannabinoid, clathrin, internalization, mutagenesis function approaches, recycling.

Download Free Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 7
Issue Number: 1
First Page: 67
Last Page: 80
Page Count: 14
DOI: 10.2174/1874467207666140714115824

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science